Bailey CJ - Search Results

1

Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease.

Bhatt DL, Szarek M, Pitt B, Cannon CP, Leiter LA, McGuire DK, Lewis JB, Riddle MC, Inzucchi SE, Kosiborod MN, Cherney DZI, Dwyer JP, Scirica BM, Bailey CJ, Díaz R, Ray KK, Udell JA, Lopes RD, Lapuerta P, Steg PG; SCORED Investigators. Bhatt DL, et al. Among authors: bailey cj. N Engl J Med. 2021 Jan 14;384(2):129-139. doi: 10.1056/NEJMoa2030186. Epub 2020 Nov 16. N Engl J Med. 2021. PMID: 33200891 Clinical Trial.

2

Metformin.

Bailey CJ, Turner RC. Bailey CJ, et al. N Engl J Med. 1996 Feb 29;334(9):574-9. doi: 10.1056/NEJM199602293340906. N Engl J Med. 1996. PMID: 8569826 Review. No abstract available.

3

Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with metformin: a randomised, double-blind, placebo-controlled trial.

Bailey CJ, Gross JL, Pieters A, Bastien A, List JF. Bailey CJ, et al. Lancet. 2010 Jun 26;375(9733):2223-33. doi: 10.1016/S0140-6736(10)60407-2. Lancet. 2010. PMID: 20609968 Clinical Trial.

4

Use of metformin in the setting of mild-to-moderate renal insufficiency.

Lipska KJ, Bailey CJ, Inzucchi SE. Lipska KJ, et al. Among authors: bailey cj. Diabetes Care. 2011 Jun;34(6):1431-7. doi: 10.2337/dc10-2361. Diabetes Care. 2011. PMID: 21617112 Free PMC article. Review. No abstract available.

5

The efficacy and safety of imeglimin as add-on therapy in patients with type 2 diabetes inadequately controlled with metformin monotherapy.

Fouqueray P, Pirags V, Inzucchi SE, Bailey CJ, Schernthaner G, Diamant M, Lebovitz HE. Fouqueray P, et al. Among authors: bailey cj. Diabetes Care. 2013 Mar;36(3):565-8. doi: 10.2337/dc12-0453. Epub 2012 Nov 16. Diabetes Care. 2013. PMID: 23160726 Free PMC article. Clinical Trial.

6

Individualized glycaemic targets and pharmacotherapy in type 2 diabetes.

Bailey CJ, Aschner P, Del Prato S, LaSalle J, Ji L, Matthaei S; Global Partnership for Effective Diabetes Management. Bailey CJ, et al. Diab Vasc Dis Res. 2013 Sep;10(5):397-409. doi: 10.1177/1479164113490765. Epub 2013 May 27. Diab Vasc Dis Res. 2013. PMID: 23711582 Free article. Review.

7

The efficacy and safety of imeglimin as add-on therapy in patients with type 2 diabetes inadequately controlled with sitagliptin monotherapy.

Fouqueray P, Pirags V, Diamant M, Schernthaner G, Lebovitz HE, Inzucchi SE, Bailey CJ. Fouqueray P, et al. Among authors: bailey cj. Diabetes Care. 2014 Jul;37(7):1924-30. doi: 10.2337/dc13-2349. Epub 2014 Apr 10. Diabetes Care. 2014. PMID: 24722500 Clinical Trial.

8

Efficacy and safety of dapagliflozin monotherapy in people with Type 2 diabetes: a randomized double-blind placebo-controlled 102-week trial.

Bailey CJ, Morales Villegas EC, Woo V, Tang W, Ptaszynska A, List JF. Bailey CJ, et al. Diabet Med. 2015 Apr;32(4):531-41. doi: 10.1111/dme.12624. Epub 2014 Nov 22. Diabet Med. 2015. PMID: 25381876 Clinical Trial.

9

Metformin in patients with type 2 diabetes and kidney disease: a systematic review.

Inzucchi SE, Lipska KJ, Mayo H, Bailey CJ, McGuire DK. Inzucchi SE, et al. Among authors: bailey cj. JAMA. 2014 Dec 24-31;312(24):2668-75. doi: 10.1001/jama.2014.15298. JAMA. 2014. PMID: 25536258 Free PMC article. Review.

10

Dapagliflozin in patients with type 2 diabetes mellitus: A pooled analysis of safety data from phase IIb/III clinical trials.

Jabbour S, Seufert J, Scheen A, Bailey CJ, Karup C, Langkilde AM. Jabbour S, et al. Among authors: bailey cj. Diabetes Obes Metab. 2018 Mar;20(3):620-628. doi: 10.1111/dom.13124. Epub 2017 Oct 26. Diabetes Obes Metab. 2018. PMID: 28950419 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

411 results

Search Page

Filters